26/08/2026
๐ Congratulations to Mr Dushyant and co-authors on the recent research, โRegenerative Approaches in Type 1 Diabetes: ฮฒ-Cell Replacement and Emerging Therapeutics,โ Published in Recent Advances in Inflammation & Allergy Drug Discovery (Impact factor 1.5; Scopus-indexed), published by Bentham Science.
This article explores emerging strategies for addressing the loss of insulin-producing ฮฒ-cells in Type 1 Diabetes. The article highlights several promising areas of research, including:
๐ฌ Stem cell-derived ฮฒ-cell replacement
๐งฌ Pluripotent and embryonic stem cell technologies
๐ก๏ธ Immunotherapy and immune-tolerance approaches
๐งซ Bioengineered islet grafting and xenotransplantation
โ๏ธ Gene-editing technologies
๐ก Encapsulation strategies to improve cell survival and function
๐ฏ Personalized and translational therapeutic approaches
These advances represent an important step toward developing therapies that may go beyond conventional insulin replacement and ultimately contribute to long-term insulin independence.
At GRIP, we remain committed to fostering research, innovation, and scientific excellence that addresses pressing healthcare challenges.